Treatment of migraine with monoclonal antibodies.

Autor: Serra López-Matencio JM; Hospital Pharmacy Division, Hospital Universitario de La Princesa, Madrid, Spain., Gago-Veiga AB; Neurology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain., Gómez M; Methodology Unit, Health Research Institute Princesa (IIS-IP), Madrid, Spain., Alañón Plaza E; Hospital Pharmacy Division, Hospital Universitario de La Princesa, Madrid, Spain., Mejía GP; Pharmacology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain., González-Gay MÁ; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, University of Cantabria, Santander, Spain., Castañeda S; Rheumatology Division, Hospital Universitario de La Princesa, Madrid, Spain.; Medicine Department, Universidad Autónoma de Madrid (UAM) and Catedra, Madrid, Spain.

Publikováno v: Expert opinion on biological therapy [Expert Opin Biol Ther] 2022 Jun; Vol. 22 (6), pp. 707-716. Date of Electronic Publication: 2022 May 13.